Form D · Other
Animal Microbiome Analytics, Inc.
Oakland, CA · CIK 0001868043
Offering snapshot reported Sep 10, 2024 · SEC filing
- Reported sold
- $15.5M Offering amount: $15.5M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 10, 2024 | Initial | $15,530,944 | No comparison | 10 | SEC filing |
| May 3, 2022 | Initial | $5,541,370 | No comparison | 5 | SEC filing |
| Jun 17, 2021 | Initial | $8,226,381 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-523631
Source: Form D, filed Sep 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gina Del Vecchio | Director |
| Mary Estakhri | Director |
| Holly Ganz | Director |
| Carlton Osborne | Director, Executive |
| Vance Vanier | Director |
| Alissa Wellington | Director |
| Jeremiah Zinn | Director |
Issuer details
Industry: Other (See others in industry)
Address:
C/O Animal Microbiome Analytics, Inc. 2945 Webster Street, 2nd Floor
Oakland, CA, 94609
Oakland, CA, 94609